Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Suzhou City, China Clinical Trials

A listing of Suzhou City, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (9) clinical trials

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

CNS leukemia is defined as unequivocal evidence of leukemic blasts in the cerebrospinal fluid by cytology or flow cytometry; cranial palsies or a nonhemorrhagic mass seen in cranial computed tomography or magnetic resonance imaging because of infiltration by leukemia cells

Phase

0.0 miles

Learn More »

A Safety and Pharmacokinetic Study Between HLX02 and Herceptin (U.S. and German) in Healthy Chinese Male Subjects

Assessment of safety of HLX02 at different doses. Randomised, double-blind, parallel group Phase I study to compare PK profiles and to assess the safety and immunogenicity between HLX02 and Herceptin (U.S. and German).

Phase

0.0 miles

Learn More »

Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)

The purpose of this study is to evaluate the pharmacokinetics and safety of posaconazole intravenous solution in Chinese participants at high risk for invasive fungal infections. Neutropenic participants undergoing chemotherapy for acute myelogenous leukemia or myelodysplastic syndromes will be enrolled in the study.

Phase

0.0 miles

Learn More »

Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors

Dose escalation study is to evaluate the safety and tolerability of KN035 in advanced and metastatic solid tumor. Six dose levels are planned and include: 0.1, 0.3, 1.0, 2.5, 5, 10 mg/kg/dose. Subjects will be assigned to a dose level in the order of study entry. The first cohort of ...

Phase

0.0 miles

Learn More »

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Cancer

1. Investigate the tolerance of Chlorogenic acid for injection in human body, determine the Maximum Tolerated Dose (MTD) and Dose-Limiting Toxicity (DLT) of Chlorogenic acid for injection in the advanced malignant tumor subjects; 2. Determine the human pharmacokinetics characteristic of Chlorogenic acid for injection; 3. Preliminary observation the effectiveness and ...

Phase

0.27 miles

Learn More »

Dose Escalation Study of JNJ-54767414 (Daratumumab) in Chinese Participants With Relapsed or Refractory Multiple Myeloma Who Failed at Least 2 Prior Lines of Systemic Therapy

The purpose of this study is to evaluate the tolerability, safety and the pharmacokinetic (PK) profile of daratumumab in Chinese participants with relapsed or refractory multiple myeloma (RRMM) who failed at least 2 prior lines of systemic therapy (Part 1 and Part 2); and to evaluate the tolerability and safety ...

Phase

3.13 miles

Learn More »

The Drug-Drug Interaction of SHR4640 Febuxostat and Colchicine in Patients With Gout

The objective of the study is to assess the pharmacodynamic properties of drug-drug of SHR4640, Febuxostat and Colchicine interaction in patients with gout.

Phase

3.13 miles

Learn More »

BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer

This is an open label, single arm Phase I study, including a "dose escalation" part and a "dose extension" part. Dose extension will be initiated during the process of dose escalation: once a dose is found to be safe and effective (evaluated according to objective response rate [ORR]) during escalation, ...

Phase

3.13 miles

Learn More »

Functional Neural Regeneration Collagen Scaffold Transplantation in Acute Spinal Cord Injury Patients

The study is designed to assess the safety and efficacy of functional neural regeneration collagen scaffold transplanted into acute spinal cord injury patients.

Phase

3.13 miles

Learn More »